SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-000015
Filing Date
2024-01-02
Accepted
2024-01-02 06:02:23
Documents
15
Period of Report
2023-12-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2333838d1_8k.htm   iXBRL 8-K 42301
2 EXHIBIT 10.1 tm2333838d1_ex10-1.htm EX-10.1 411034
3 EXHIBIT 99.1 tm2333838d1_ex99-1.htm EX-99.1 18870
7 GRAPHIC tm2333838d1_img001.jpg GRAPHIC 15297
  Complete submission text file 0001104659-24-000015.txt   782217

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA vrna-20231227.xsd EX-101.SCH 3027
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrna-20231227_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrna-20231227_pre.xml EX-101.PRE 22367
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2333838d1_8k_htm.xml XML 3321
Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE 011-44-0-2032834200
Verona Pharma plc (Filer) CIK: 0001657312 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38067 | Film No.: 24500037
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)